The ICCR has been formed to develop common, internationally standardised and evidence-based cancer datasets for surgical pathology specimens. Using the best international approaches, and leveraging the knowledge and experience of world-leading pathologists, the ICCR aims to ensure that all cancer reports, will be of the same high quality; ensuring completeness, consistency, clarity, conciseness and above all, clinical utility. The ICCR has published 62 cancer datasets to date which are available here.
Deadline for comments: 29 August 2025
IAP colleagues are invited to review the following draft International Collaboration on Cancer Reporting (ICCR) Endocrine datasets:
Carcinoma of the adrenal cortex (2nd edition)
Parathyroid carcinoma and atypical parathyroid neoplasm (2nd edition)
Phaeochromocytoma and paraganglioma (2nd edition)
Carcinoma of the thyroid (3rd edition)
The draft datasets are available for comment until Friday 29th August 2025.
Deadline for comments: 26 September 2025
IAP colleagues are invited to review the following draft International Collaboration on Cancer Reporting (ICCR) Skin datasets:
Merkel cell carcinoma (2nd edition)
Invasive melanoma (3rd edition)
The draft datasets are available for comment until Friday 26th September 2025.
Released September 2 2024
Released August 11th 2024